Table 3.
Type of study (in vitro, in vivo, human subjects) | Arsenical exposure | Cell type analyzed | Type of miRNA analysis and method used | Major findings | Reference |
---|---|---|---|---|---|
In vitro exposure to arsenite (immortalized human bronchial epithelial cell line) | 0, 10, 15, 20 μM arsenic chloride for 24 h | Human immortalized bronchial epithelial cell line BEAS-2B | Total RNA analyzed for levels of 95 cancer-related miRNAs using a miRNA qPCR array. Subsequent analysis of miR-190 levels using real-time qPCR. | Arsenite exposure correlated with dose-dependent increase in miR-190. miR-190 overexpression alone sufficient for acquisition of malignant characteristics in BEAS-2B. | Beezold et al., 2011 [77] |
In vitro exposure to ATO (human hepatocellular carcinoma cell line) | 4 μM ATO (As2O3) for 24 h | Human hepatocellular carcinoma cell line Hep-G2 | Total RNA analyzed for levels of 677 human miRNAs using a miRNA PCR array. Levels of selected miRNAs analyzed using real-time qPCR. | Identified miR-29a as a likely critical mediator of ATO-mediated apoptosis and inhibition of cell growth. | Meng et al., 2011 [73] |
In vitro exposure to arsenite (immortalized human bronchial epithelial cell line) | 2.5 μM arsenite (NaAsO2) for 16 weeks, resulting in malignant transformation |
Immortalized human bronchial epithelial cell line p53low HBEC, which contains stable shRNA knockdown of TP53 |
Total RNA analyzed for levels of 856 human miRNAs using a miRNA PCR array. Levels of selected miRNAs also analyzed using real-time qPCR. | Malignant transformation associated with reduction of miR-200 family members; downregulation of miR-200b shown to be essential for malignant transformation. | Wang et al., 2011 [76] |
In vivo exposure to arsenite (chick embryos); in vitro exposure to arsenite (human umbilical cord vein cell line) | 100 nM arsenite (NaAsO2) injected in yolk sac of chick embryos at HH stages 6, 9, and 12; embryos harvested at HH stage 18. EA.hy926 cells exposed to 100 nM arsenite (NaAsO2) for 72 h | White Leghorn chick (Bovan strain) whole embryos; human umbilical cord vein cell line EA.hy926 | Total RNA analyzed for miRNA levels using several methods including miRNA PCR arrays and real-time qPCR and Northern blots of selected targets. | miR-9 and miR-181b implicated as potential mediators of the toxic developmental effects of arsenic, specifically abnormal angiogenesis. | Cui et al., 2012 [75] |
In vitro exposure to ATO (APL cell line) | Therapeutic dose of 2 μM ATO (As2O3) for 24 h | human APL cell line NB4 | Total RNA analyzed for levels of 88 cancer-associated human miRNAs using a miRNA PCR array. | Exposure modulated 88 cancer-associated miRNAs, including those predicted to bind mRNAs of genes involved in cell cycle and apoptosis. | Ghaffari et al., 2012 [72] |
In vitro exposure to arsenite (immortalized human embryonic lung fibroblasts) | 1.0 μM arsenite (NaAsO2) for ~15 weeks, resulting in acquisition of malignant characteristics | Immortalized human embryonic lung fibroblast cell line HELF | Total RNA analyzed for miR-21 levels using real-time qPCR. | Identified ROS-sensitive pathways as inducers of miR-21. MiR-21 upregulation implicated as important event in the acquisition of malignant characteristics. | Ling et al., 2012 [78•] |
APL: acute myelocytic leukemia
ATO: arsenic trioxide
HH: Hamburger-Hamilton
qPCR: quantitative polymerase chain reaction
ROS: reactive oxygen species